NRx Pharmaceuticals Says 'Both NRX-101 and Lurasidone, an Accepted Standard of Care in Bipolar Depression, Demonstrated Approximately 50% Reduction in Symptoms of Depression'
nRx Pharmicals 表示:“NRX-101 和雙相抑鬱症的公認護理標準盧拉西酮均顯示抑鬱症狀減輕了大約 50%”
NRx Pharmaceuticals Says 'Both NRX-101 and Lurasidone, an Accepted Standard of Care in Bipolar Depression, Demonstrated Approximately 50% Reduction in Symptoms of Depression'
nRx Pharmicals 表示:“NRX-101 和雙相抑鬱症的公認護理標準盧拉西酮均顯示抑鬱症狀減輕了大約 50%”
使用瀏覽器的分享功能,分享給你的好友吧